Best Practices in Improving Medical Affairs Booth Impact at Critical Medical Congresses

Industries Profiled:
Biotech; Pharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Biopharmaceutical; Health Care


Companies Profiled:
Amgen; Astellas; Bayer; Chiesi Global Rare Diseases; EMD Serono; Ipsen; Incyte; Morphic Therapeutic; Novartis; OPEN Health; Protagonist Therapeutics; Purdue Pharma; Regeneron; Takeda Pharmaceuticals; Teva Pharmaceuticals; Vertex Pharmaceuticals; Xenon Pharmaceuticals

Study Snapshot

Best Practices, LLC engaged 20 Medical Communications and Scientific Publications leaders from 17 biopharma companies for this research project. The research employed a quantitative survey as the primary method of data collection, supplemented by qualitative insights to enhance the findings.

Key topics covered in this report include:

• Medical Affairs Booth Content
• Display Methods for Medical Booth Content
• Approaches to US and EU Content
• Measuring Medical Booth Success
• Poster/Investigator Events at Congresses
• Medical Content Utilized by MSLs in the Field

• Medical Booth Content and Display: Disease state and pipeline information are shared with congress attendees by a variety of new and traditional means (e.g., static panels, websites, videos, other interactive media). 90-95% of organizations share this information proactively at booths.

• Medical booth impact: Research overview, objectives, methodology, and topics
• Benchmark study partners
• Study definitions
• Key study findings

• Top 5 booth content types shared per display method
• Types of content shared and displayed at medical booths at congresses
• Interview narrative around the factors impacting content display at medical information/medical affairs booth
• Most important factors affecting a biopharma company’s decision for booth content selection
• Content types and formats available at virtual booths
• Interview narrative around embracing a mix of technologies to bring attendees to the booth and engage them effectively
• Most valuable interactive elements for enhancing the learning experience at medical affairs booths
• Interview narrative around effectiveness of interactive games
• Differentiation of US, EU, APAC, and other regional information at international congress booths
• Interview narratives around differentiating medical booth information as per the region

• Effective medical booth strategies to pique the attendees’ interest
• Metrics for evaluating medical booth content impact and effectiveness
• Comparison of most valuable vs. widely-used metrics for assessing medical information/medical affairs booth content effectiveness
• Channels used to send posters or other content to congress attendees
• Permissions for e-mail distribution of posters and content to congress attendees
• Top practices for medical information/affairs booth content and display at congresses
• Top pitfalls in medical booth content and display at congresses

• Hosting poster/investigator receptions at congresses and content utilized
• Re-use of content from previous congresses at poster receptions and the age of materials used
• Restrictions on poster/investigator reception attendance at congresses

• Materials used by MSL teams in the field and sharing methods (proactive vs. reactive)
• Content availability and sharing methods at congress events
• Adopting innovative MSL materials
• Sharing innovative MSL materials
• MSL utilization of poster books in the field
• MSL-hosted receptions at medical congresses and attendee eligibility